Assessment of the contribution of the IHC4+C score to decision making in clinical practice in early breast cancer

BACKGROUND: The immunohistochemical (IHC) 4+C score is a cost-effective prognostic tool that uses clinicopathologic factors and four standard IHC assays: oestrogen receptor (ER), PR, HER2 and Ki67. We assessed its utility in personalising breast cancer treatment in a clinical practice setting, throu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Barton, S, Zabaglo, L, A'Hern, R, Turner, N, Ferguson, T, O'Neill, S, Hills, M, Smith, I, Dowsett, M
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2012
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3364112/
https://ncbi.nlm.nih.gov/pubmed/22531639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2012.166
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados